Esposito Named CEO Armune BioScience: Lands $2.5 Million In Funding
KALAMAZOO - David A. Esposito has been named President and Chief Executive Officer of Armune BioScience, succeeding the founding and outgoing President and CEO, Eli L. Thomssen, who becomes Chief Business Officer. Armune also completed the first close on a $2.5 million Series A financing round designed to underwrite the launch of Apifiny, its, non-PSA